Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLPHENIDATE Cause Agranulocytosis? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Agranulocytosis have been filed in association with METHYLPHENIDATE (Methylphenidate Hydrochloride). This represents 0.0% of all adverse event reports for METHYLPHENIDATE.

5
Reports of Agranulocytosis with METHYLPHENIDATE
0.0%
of all METHYLPHENIDATE reports
3
Deaths
2
Hospitalizations

How Dangerous Is Agranulocytosis From METHYLPHENIDATE?

Of the 5 reports, 3 (60.0%) resulted in death, 2 (40.0%) required hospitalization.

Is Agranulocytosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHYLPHENIDATE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does METHYLPHENIDATE Cause?

Drug ineffective (4,924) Off label use (4,842) No adverse event (4,197) Product quality issue (1,728) Disturbance in attention (1,414) Product substitution issue (1,408) Anxiety (1,356) Drug dose omission (1,330) Headache (1,255) Wrong technique in product usage process (1,250)

What Other Drugs Cause Agranulocytosis?

CLOZAPINE (1,766) CYCLOPHOSPHAMIDE (1,242) RITUXIMAB (1,154) SULFAMETHOXAZOLE\TRIMETHOPRIM (797) PANTOPRAZOLE (599) METHOTREXATE (550) SODIUM (549) EPIRUBICIN (491) METAMIZOLE (438) DOCETAXEL (436)

Which METHYLPHENIDATE Alternatives Have Lower Agranulocytosis Risk?

METHYLPHENIDATE vs METHYLPREDNISOLONE METHYLPHENIDATE vs METHYLPREDNISOLONE ACEPONATE METHYLPHENIDATE vs METHYLPREDNISOLONE HEMISUCCINATE METHYLPHENIDATE vs METILDIGOXIN METHYLPHENIDATE vs METOCLOPRAMIDE

Related Pages

METHYLPHENIDATE Full Profile All Agranulocytosis Reports All Drugs Causing Agranulocytosis METHYLPHENIDATE Demographics